SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹33 Cr | ₹29 Cr | ₹25 Cr | ₹19 Cr | ₹31 Cr |
What is the latest Total Non-Current Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹19 Cr |
| Mar2021 | ₹31 Cr |
How is Total Non-Current Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | 15.24 | |
| Mar2024 | ₹29 Cr | 15.72 | |
| Mar2023 | ₹25 Cr | 29.23 | |
| Mar2022 | ₹19 Cr | -37.22 | |
| Mar2021 | ₹31 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹5,367.3 Cr | 0.7% | -9.8% | 6.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 0.7% |
-9.8% |
6.8% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses